Phenogenomic characterization of immunomodulatory purinergic signaling in glioblastoma.

被引：0

作者：

Coy, Shannon ^{[1
]}

Lin, Jia-Ren ^{[1
]}

Wang, Shu ^{[1
]}

Stopka, Sylwia ^{[2
]}

Rashid, Rumana ^{[3
]}

Hwang, Jaeho ^{[4
]}

Khadka, Prasidda ^{[5
]}

Euskirchen, Philipp ^{[6
]}

Bandopadhayay, Pratiti ^{[5
]}

Wen, Patrick Y. ^{[5
]}

Sorger, Peter K. ^{[1
]}

Agar, Nathalie ^{[2
]}

Ligon, Keith L. ^{[7
]}

Touat, Mehdi ^{[8
]}

Santagata, Sandro ^{[2
]}

机构：

[1] Harvard Med Sch, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA

[4] Johns Hopkins Univ, Baltimore, MD USA

[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Charite Univ Med Berlin, Berlin, Germany

[7] Harvard Med Sch, Brigham & Womens Hosp, Dana, Boston, MA 02115 USA

[8] La Pitie Salpetriere Charles Foix Univ Hosp, Paris, France

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1816

引用

页数：2

共 50 条

[41] Demographic disparities influencing survival of patients with glioblastoma.
Ayoobkhan, Fathima Shehnaz
Ganiyani, Mohammad Arfat
Pustake, Manas
Ahmad, Shahzaib
Podder, Vivek
Bellur, Shreyas S.
Howal, Prashant
Shah, Aditya
Goodman, Judie R.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[42] Early palliative care interventions in patients with glioblastoma.
Ambady, Prakash
Hambelton, Connor
Fu, Rongwei
Firkins, Jenny
Neuwelt, Edward A.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[43] Blood alterations preceding clinical manifestation of glioblastoma.
Ilhan-Mutlu, Aysegul
Wagner, Ludwig
Woehrer, Adelheid
Susanne, Jungwirth
Marosi, Christine
Fischer, Peter
Preusser, Matthias
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[44] Comparison of Two oHSV Vectors for the Treatment of Glioblastoma.
Jackson, Joseph W.
Hall, Bonnie L.
Bailey, Lisa
Queva, Christophe
Chiocca, E. Antonio
Cohen, Justus B.
Glorioso, Joseph C.
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
[45] Evaluation of the impact of necrosis on gene expression in glioblastoma.
Dumur, CI
Van Meter, TE
Hafez, N
Archer, KJ
Ferreira-Gonzalez, A
Wilkinson, DS
Broaddus, WC
Garrett, CT
JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 682 - 682
[46] MOLECULAR PROFILING OF PRIMARY VERSUS RECURRENT GLIOBLASTOMA BRAIN TUMOR STEM CELLS UNCOVERS SIGNALING MECHANISMS THAT PROMOTE THE AGGRESSIVENESS OF RECURRENT GLIOBLASTOMA.
Heemskerk, Kyle
Hao, Xiaoguang
Cseh, Orsolya
Luchman, H. Artee
Weiss, Samuel
NEURO-ONCOLOGY, 2022, 24 : 31 - 31
[47] Digital measurement of functional status of patients with glioblastoma.
Damestani, Yasaman
Mehta, Minesh P.
Colman, Howard
Camphausen, Kevin A.
Weller, Michael
Galanis, Evanthia
Van Den Bent, Martin J.
De Groot, John Frederick
Lassman, Andrew B.
Hottinger, Andreas Felix
Nabors, Louis B.
Duic, J. Paul
Li, Kai
Liu, Yang
Tang, Shijie
Tamir, Sharon
Shacham, Eran
Shah, Jatin J.
Shacham, Sharon
Wen, Patrick Y.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[48] Circulating tumor cells as prognostic biomarkers in glioblastoma.
Bark, Juliana Muller
Kulasinghe, Arutha
Leo, Paul
Hartel, Gunter
Warkiani, Majid E.
Jeffree, Rosalind L.
Chua, Benjamin
Day, Bryan W.
Punyadeera, Chamindie
CANCER RESEARCH, 2021, 81 (13)
[49] Profiling response to carmustine/bevacizumab in recurrent glioblastoma.
Rojas, Leonardo
Cardona, Andres F.
Wills, Beatriz
Arrieta, Oscar
Vargas, Carlos A.
Carranza, Hernan
Otero, Jorge M.
Useche, Nicolas
Bermudez, Sonia
Jimenez, Enrique
Hakim, Fernando
Balana, Carmen
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[50] Effect of Epo and EpoR expression on the Survival in Glioblastoma.
Strik, H.
Brunotte, J.
Hemmerlein, B.
Brueck, W.
ONKOLOGIE, 2010, 33 : 59 - 60

← 1 2 3 4 5 →